Related Experiment Videos
Transient abnormal myelopoiesis in Down's syndrome
H Kurahashi1, J Hara, K Yumura-Yagi
1Department of Pediatrics, Osaka University Hospital, Fukushima, Japan.
Leukemia & Lymphoma
|December 1, 1992
Summary
Transient abnormal myelopoiesis (TAM) is a clonal stem cell disorder. Its spontaneous regression mechanism, possibly involving immune surveillance or apoptosis, remains unclear.
Area of Science:
- Hematology
- Genetics
- Developmental Biology
Background:
- Transient abnormal myelopoiesis (TAM) is a monoclonal disorder affecting multipotent stem cells.
- It is closely linked to genetic abnormalities on chromosome 21, potentially leading to acute megakaryoblastic leukemia (AMKL).
Purpose of the Study:
- To elucidate the pathogenesis of TAM.
- To understand the mechanisms underlying the spontaneous regression of TAM.
- To explore the relationship between TAM and AMKL.
Main Methods:
- Review of recent data on TAM pathogenesis.
- Analysis of the genetic factors associated with TAM and AMKL.
- Hypothesizing mechanisms for spontaneous regression.
Main Results:
- TAM originates from a multipotent stem cell clone.
- Genetic alterations on chromosome 21 are implicated in TAM and AMKL development.
- AMKL arising after TAM regression likely originates from the same clone.
Conclusions:
- The gene responsible for TAM is expected to be cloned soon.
- The spontaneous regression of TAM is not yet understood.
- Potential mechanisms include immune system maturation or programmed cell death (apoptosis).